Table 2.
F-18 Fluciclovine–Positive Region Identified by an Experienced Nuclear Medicine Physician
| Region (n = 17) | n (%) |
| Prostate bed only | 8 (47%) |
| Prostate bed + pelvic lymph nodes | 4 (24%) |
| Extrapelvic sitesa | 5 (29%) |
The extrapelvic sites include retroperitoneal lymph node or bone lesion.